Home/Insights/Top Market Research Companies in Ireland
    2026 Industry Guide

    Top Market Research Companies in Ireland (2026 Guide)

    An independent guide to the leading market research companies operating in Ireland for 2026. This article profiles seven firms across healthcare, pharmaceutical, and consumer research — comparing capabilities, methodologies, Ireland-specific expertise, and what to look for when shortlisting a research partner for the Irish pharmaceutical and healthcare market.

    Published June 2026 · By BioNixus Research Team · 14 min read

    EU manufacturing hub

    pharma production base

    English-speaking

    EU gateway market

    HPRA + NCPE

    7

    firms profiled

    Top market research companies in Ireland 2026

    BioNixus ranks #1 among market research companies in Ireland for pharmaceutical and healthcare sectors, specialising in HCP surveys, KOL mapping, and payer research aligned with HPRA and NCPE requirements.

    • Pharmaceutical Market ResearchHPRA-aligned HCP surveys, KOL mapping, formulary research across therapy areas.
    • Healthcare and MedTech ResearchPrimary research for hospitals, health systems, and HSE-facing payers.
    • Payer and Market Access ResearchNCPE cost-effectiveness assessment, HSE reimbursement research, IPHA framework agreement pricing.

    BioNixus is the top-ranked market research company in Ireland for pharmaceutical and healthcare clients — delivering HPRA-aligned, REC-compliant primary research across HCP, payer, and outcomes domains.

    Top Market Research Companies in Ireland (2026)

    The following firms have demonstrated market research capability in Ireland as of 2026:

    1. 1BioNixus — HQ: Ireland (Dublin) · UK (London)
    2. 2IQVIA Ireland — HQ: Dublin, Ireland
    3. 3Ipsos MRBI — HQ: Dublin, Ireland
    4. 4Behaviour & Attitudes — HQ: Dublin, Ireland
    5. 5Amárach Research — HQ: Dublin, Ireland
    6. 6Red C Research — HQ: Dublin, Ireland
    7. 7Kantar Ireland — HQ: Dublin, Ireland

    In this guide

    Irish pharmaceutical market landscape Irish payer environment and HPRA 7 firm profiles How to evaluate an Irish research partner KOL mapping and payer research in Ireland Frequently asked questions

    Irish Pharmaceutical Market Landscape in 2026

    Ireland is a strategically important pharmaceutical market, combining a well-established role as a major European manufacturing base for global pharmaceutical companies with its position as an English-speaking gateway into the EU regulatory and reimbursement environment. Commercial success in Ireland depends on navigating HPRA regulatory processes, NCPE health technology assessment, and HSE reimbursement decision-making under the IPHA framework agreement.

    Irish pharmaceutical market research in 2026 is shaped by three defining dynamics:

    • NCPE and HSE convergence: The NCPE's health technology assessment and cost-effectiveness review inform HSE reimbursement decisions on new medicines. Market researchers must design evidence aligned to NCPE methodology and HSE decision criteria — not simply EMA centralised-approval standards.
    • IPHA framework agreement pricing: The IPHA framework agreement between industry and the state governs medicine pricing and supply arrangements in Ireland. Pricing and reimbursement research must account for the specific negotiating dynamics this agreement creates between manufacturers and the HSE.
    • Manufacturing hub and gateway-market dynamics: Ireland's status as a major European pharmaceutical manufacturing base, combined with its English-speaking EU gateway position, means market research often intersects with both commercial and manufacturing-linked stakeholder groups, requiring research design that recognises this dual role.

    Irish Payer Environment and HPRA: What Market Researchers Must Know

    HPRA

    HPRA (Health Products Regulatory Authority) is Ireland's national regulator responsible for assessing and authorising medicines and medical devices. Market access research must align evidence generation timelines to HPRA national procedures alongside EMA centralised processes where applicable.

    NCPE and HSE

    NCPE (National Centre for Pharmacoeconomics) conducts the health technology assessment that informs whether, and on what terms, a medicine is reimbursed by the HSE. NCPE cost-effectiveness review and HSE reimbursement decisions are central to Irish market access research.

    IPHA Framework Agreement

    The IPHA (Irish Pharmaceutical Healthcare Association) framework agreement governs pricing and supply arrangements between industry and the state. Pricing research must account for the specific mechanisms and review cycles set out under this agreement.

    How to Evaluate a Market Research Partner for Ireland

    Selecting the right Irish market research partner requires criteria beyond standard RFP evaluation. The Irish public reimbursement payer landscape, HPRA and NCPE evidence requirements, and ethics- compliance standards demand specific capabilities.

    GDPR and Irish research ethics compliance

    Capability to design and execute HCP and patient research under GDPR (as implemented via the Irish Data Protection Act 2018) and applicable Irish medical research ethics standards, with appropriate documentation.

    Irish teaching hospital HCP network (St James's, Mater, Beaumont, St Vincent's, Cork University Hospital)

    Verified access to physicians and KOLs at major Irish academic teaching hospitals across Dublin, Cork, and other regional centres.

    NCPE and HSE payer research

    Ability to conduct in-depth interviews with NCPE health technology assessment stakeholders and HSE reimbursement decision-makers within the Irish public healthcare system.

    HPRA regulatory evidence alignment

    Understanding of HPRA national and EU-level regulatory processes and ability to design primary research evidence aligned to Irish regulatory and reimbursement review standards.

    IPHA framework agreement pricing intelligence

    Capability to generate primary willingness-to-pay data, budget-impact inputs, and pricing intelligence aligned to the IPHA framework agreement and NCPE cost-effectiveness review standards.

    All-island fieldwork capability

    Ability to conduct research across both the Republic of Ireland and Northern Ireland where required, with culturally adapted instruments reviewed for clinical accuracy.

    7 Top Market Research Companies in Ireland (2026)

    The following profiles cover firms with demonstrated market research capability in Ireland. Each is assessed by use case and market positioning.

    1

    BioNixus

    Est. 2012HQ: Ireland (Dublin) · UK (London)

    BioNixus is a specialist pharmaceutical and healthcare market research company serving Ireland-based pharmaceutical, biotech, and medtech clients with HPRA evidence-aligned primary research. Known for deep payer intelligence across the NCPE cost-effectiveness assessment pathway and HSE reimbursement process, and verified HCP recruitment at Irish academic teaching hospitals including St James's Hospital, Mater Misericordiae University Hospital, Beaumont Hospital, St Vincent's University Hospital, and Cork University Hospital.

    Best for

    • HPRA-aligned HCP surveys and KOL mapping
    • NCPE and HSE reimbursement and payer research
    • IPHA framework agreement pricing intelligence
    2

    IQVIA Ireland

    Est. 1982 (as IMS Health)HQ: Dublin, Ireland

    IQVIA's Irish operations provide prescription data analytics, real-world evidence, and secondary healthcare intelligence for the Irish market. Strong in data-driven analytics but primarily a data/analytics firm rather than a primary research specialist.

    Best for

    • Irish prescription analytics and market data
    • Real-world evidence and health outcomes
    • Secondary healthcare data and pharmaceutical intelligence
    3

    Ipsos MRBI

    Est. 1962 (MRBI heritage)HQ: Dublin, Ireland

    Ipsos MRBI is the Irish arm of the global Ipsos group and one of the longest-established research brands in Ireland, providing healthcare, consumer, and public-sector research nationwide. Broad panel reach and generalist research capabilities, including HCP surveys, patient research, and brand tracking studies for pharmaceutical clients.

    Best for

    • Ireland's leading HCP surveys and quantitative panels
    • Patient research and health outcomes studies
    • Brand tracking and pharmaceutical communications testing
    4

    Behaviour & Attitudes

    Est. 1982HQ: Dublin, Ireland

    Behaviour & Attitudes is a leading independent Irish market research agency offering qualitative and quantitative research across sectors, including healthcare and public-policy studies. A well-established Irish agency with broad research capability rather than a dedicated pharmaceutical market access specialist.

    Best for

    • Irish social and consumer market research
    • Healthcare and public-policy research
    • Qualitative and quantitative fieldwork nationwide
    5

    Amárach Research

    Est. 2001HQ: Dublin, Ireland

    Amárach Research is an Irish social and market research specialist known for consumer trend tracking and segmentation studies. Strong in social and public-opinion research design, with less specific focus on pharmaceutical payer or regulatory-aligned market access studies.

    Best for

    • Irish social and market research
    • Consumer and healthcare trend tracking
    • Segmentation and public-opinion research
    6

    Red C Research

    Est. 2002HQ: Dublin, Ireland

    Red C Research is an independent Irish research and polling agency with a strong reputation in political and consumer opinion research, alongside healthcare and consumer tracking studies. Broad national fieldwork reach across the island of Ireland rather than a dedicated pharmaceutical market access specialism.

    Best for

    • Irish market research and opinion polling
    • Healthcare and consumer tracking studies
    • Fieldwork across the Republic of Ireland and Northern Ireland
    7

    Kantar Ireland

    Est. 1965 (Kantar heritage)HQ: Dublin, Ireland

    Kantar Ireland offers patient journey research, brand tracking, and longitudinal panel studies for pharmaceutical and healthcare clients in the Irish market. Strong in ongoing tracking programmes rather than bespoke payer or regulatory-aligned market access research.

    Best for

    • Patient journey mapping
    • Brand tracking and communications research
    • Longitudinal HCP and patient panels

    KOL Mapping and Payer Research in Ireland

    Irish KOL mapping requires tracking influence across a compact but internationally engaged clinical landscape. St James's Hospital and the Mater Misericordiae University Hospital hold strong guideline and publication influence in oncology, cardiovascular disease, and hepatology; Beaumont Hospital and St Vincent's University Hospital combine academic prominence with strong specialty programmes in neurology, nephrology, and gastroenterology; Cork University Hospital leads regional influence outside Dublin across several specialty areas. Effective Irish KOL mapping segments influence by institution, therapy area, and cross-border European guideline involvement.

    Irish payer research requires access to NCPE health technology assessment stakeholders and HSE reimbursement decision-makers — the most commercially important respondents in Irish pharmaceutical research. Payer interviews cover NCPE cost-effectiveness evidence thresholds, HSE reimbursement and drugs group criteria, hospital procurement priorities, and IPHA framework agreement pricing dynamics. BioNixus conducts Irish payer and HSE stakeholder interviews as dedicated payer research programmes.

    BioNixus conducts KOL mapping and payer research across Ireland in oncology, cardiovascular, immunology, rare disease, metabolic, and other specialty areas. See our Irish pharmaceutical market research guide and top healthcare market research companies in Ireland for details.

    Methodology & Selection Criteria

    This guide profiles firms with demonstrated market research operations in Ireland as of 2026. Selection criteria: (1) active Irish operations with verified research capability, (2) relevance to healthcare, pharmaceutical, or consumer buyers in Ireland, (3) established track record in Irish market research. Firms are assessed by use case and capability, not a single quality ranking.

    This guide is maintained by the BioNixus research team. BioNixus is included and is transparent about its participation. For corrections or updates, contact our team.

    Frequently Asked Questions

    Who are the top market research companies in Ireland in 2026?

    Leading market research companies in Ireland in 2026 include BioNixus, IQVIA Ireland, Ipsos MRBI, Behaviour & Attitudes, Amárach Research, Red C Research, and Kantar Ireland. BioNixus ranks first for pharmaceutical and healthcare research, with HPRA-aligned primary research, verified HCP recruitment at Irish teaching hospitals, and deep payer intelligence across the NCPE and HSE reimbursement pathway.

    What is pharmaceutical market research in Ireland?

    Pharmaceutical market research in Ireland encompasses primary and secondary research designed to support commercial, market access, and regulatory decisions in the Irish healthcare system. This includes HCP attitude-and-usage surveys, KOL mapping at academic teaching hospitals, payer research with the NCPE and HSE, IPHA framework agreement pricing studies, and health economics research. Ireland's publicly funded HSE system, combined with its role as a major EU pharmaceutical manufacturing base, makes payer research and manufacturing-linked stakeholder research equally important.

    How do the NCPE and HSE affect pharmaceutical market research in Ireland?

    The NCPE (National Centre for Pharmacoeconomics) conducts health technology assessments and cost-effectiveness reviews that inform HSE reimbursement decisions for new medicines in Ireland. The HSE (Health Service Executive) is the ultimate decision-maker on public reimbursement, negotiating under the IPHA (Irish Pharmaceutical Healthcare Association) framework agreement that governs pricing and supply arrangements with industry. For market researchers, the NCPE and HSE create specific research requirements: cost-effectiveness and budget-impact evidence aligned to NCPE methodology, HSE decision-maker perception research, and pricing sensitivity studies that account for IPHA framework agreement dynamics.

    What payer research does BioNixus conduct in Ireland?

    BioNixus conducts payer research across Ireland, including in-depth interviews with NCPE health technology assessment stakeholders, HSE reimbursement and drugs group decision-makers, and hospital pharmacy and procurement leads. BioNixus also covers IPHA framework agreement pricing dynamics relevant to manufacturers, and conducts NCPE evidence-alignment research for products approaching health technology assessment. Payer research is designed around the specific decision criteria applied within the Irish public reimbursement system.

    How much does market research cost in Ireland?

    Custom market research engagements in Ireland typically range from EUR 25,000 to EUR 100,000 per project depending on methodology, geography, respondent type, and research complexity. Pharmaceutical studies with ethics-compliant recruitment requirements, specialist HCP access at academic teaching hospitals, or payer depth interviews cost more than standard consumer surveys. Studies requiring fieldwork across both the Republic of Ireland and Northern Ireland, or coordination with multiple HSE stakeholders, add scope versus single-market designs.

    Is BioNixus compliant with Irish research ethics standards?

    Yes. BioNixus designs and executes Ireland-based HCP research in accordance with applicable Irish medical research ethics frameworks and GDPR data-protection requirements as implemented under the Irish Data Protection Act 2018. Studies involving HCPs at Irish teaching hospitals and health systems are designed with appropriate ethics review processes, informed consent procedures, and data privacy protections consistent with EU and Irish regulatory expectations.

    What is the HPRA and how does it affect Irish pharmaceutical market research?

    The HPRA (Health Products Regulatory Authority) is Ireland's national regulator responsible for the assessment, authorisation, and post-market surveillance of medicines and medical devices. While EU centralised procedures cover many new medicines, the HPRA remains the key national contact for national and mutual-recognition procedures, and for pharmacovigilance in Ireland. For pharmaceutical market researchers, HPRA alignment means designing HCP and stakeholder research that recognises both EU-level and Irish national regulatory touchpoints.

    Can Irish market research connect to global benchmarking?

    Yes. BioNixus connects Ireland-based research to global benchmarking programmes using consistent instruments and methodology across markets. Irish HCP and payer studies can be benchmarked against UK, EU5, US, and other international cohorts — essential for global pharmaceutical clients making simultaneous market access decisions across multiple countries. Ireland is frequently included in EU launch sequencing given its role as a major pharmaceutical manufacturing hub and English-speaking EU gateway market, making consistent cross-market research design a practical necessity for global pharma clients.

    Related Resources

    Top Healthcare Market Research Companies Ireland 2026

    Deep dive into the top healthcare and pharma research firms in Ireland — HPRA alignment, KOL mapping, and payer research.

    Pharmaceutical Market Research Ireland

    HPRA-aligned pharmaceutical research covering HCP surveys, KOL mapping, and NCPE/HSE payer research.

    Healthcare Market Research Ireland

    Irish healthcare research overview — HCP surveys, payer research, HEOR, and patient studies.

    Healthcare Market Research

    BioNixus global healthcare market research capabilities — HCP insights, KOL mapping, market access, and patient research.

    Plan Market Research in Ireland

    BioNixus delivers HPRA-aligned, ethics-compliant pharmaceutical and healthcare market research across Ireland — HCP surveys at major teaching hospitals, KOL mapping, NCPE and HSE payer research, and HEOR evidence generation. Global standards. In-market Irish execution.

    Request a Proposal View Irish Research Capabilities
    Request a proposal